Cargando…

Headache research - where are we heading?

Detalles Bibliográficos
Autor principal:	Jensen, Rigmor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2013
Materias:	Invited Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620069/ http://dx.doi.org/10.1186/1129-2377-14-S1-I3

Ejemplares similares

Early exposure hypothesis: where are we now?
por: Lack, Gideon
Publicado: (2011)

Metabolism and headache
por: Rainero, Innocenzo
Publicado: (2015)

The value of epidemiology in headache
por: Beghi, Ettore
Publicado: (2015)

The costs of headache disorders
por: Mennini, Francesco Saverio, et al.
Publicado: (2015)

Secondary headache in emergency
por: Carolei, Antonio, et al.
Publicado: (2015)

The multimodal treatment in headaches
por: Lacerenza, Marco R, et al.
Publicado: (2015)

Medication-overuse headache: an update
por: Sarchielli, Paola
Publicado: (2015)

Osmophobia in adult and juvenile headache patients
por: Zanchin, Giorgio
Publicado: (2015)

Non headache phenotypes in pediatric age
por: Valeriani, Massimiliano
Publicado: (2015)

Neurophysiologic peculiarities of pediatric primary headaches
por: Valeriani, Massimiliano
Publicado: (2015)

Hemicrania continua and unilateral headaches: are they still together in the IHS classification?
por: Antonaci, Fabio, et al.
Publicado: (2015)

Pain processing in primary headaches, from spinal sensitisation to cortical modulation
por: Perrotta, Armando
Publicado: (2015)

Headache and psychopathology: DSM-V vs ICHD-3β vs ICD10
por: Pompili, Maurizio
Publicado: (2015)

Do we need to demonstrate Amyloid in tissue?
por: Magy, Laurent
Publicado: (2015)

Genomics-based breeding in forest trees: are we there yet?
por: Neale, David
Publicado: (2011)

Genome-forward oncology: how do we get there?
por: Ellis, Matthew
Publicado: (2011)

Do we need to demonstrate amyloid in tissue for hereditary ATTR amyloidosis ?
por: Westermark, Per
Publicado: (2015)

PReS13-SPK-1582: Activity and damage - we have to measure them
por: Feldman, BM
Publicado: (2013)

PReS13-SPK-1028: Activity and damage - we have to measure them
por: Brunner, H
Publicado: (2013)

Recruitment to trials - why is it hard and how might we make it less so?
por: Treweek, Shaun
Publicado: (2011)

Hydrocephalus treatment and outcome in African infants with myelomeningocele: what we have learned so far
por: Warf, Benjamin C
Publicado: (2010)

PReS13-SPK-1247: Activity and damage in juvenile systemic sclerosis- we have to measure them
por: Foeldvari, I
Publicado: (2013)

INSP-06. Recent advances in improving neuropsychological outcomes for paediatric brain tumour patients - Are we entering a new era?
por: Mabbott, Donald
Publicado: (2022)

Translational research at acute HIV Infection
por: Routy, Jean Pierre
Publicado: (2010)

Eucalyptus research in the post-genome era
por: Pappas, Georgios, et al.
Publicado: (2011)

Research and development for the malaria elimination/eradication roadmap
por: Tanner, Marcel, et al.
Publicado: (2010)

The UK Medical Research Council and clinical trials, 1934-1960
por: Chalmers, Iain
Publicado: (2013)

Unfinished health systems and policy research agendas for ASEAN Economic Community
por: Pannarunothai, Supasit
Publicado: (2014)

Clinical utility of thresholds versus CRD
por: Bindslev-Jensen, Carsten
Publicado: (2011)

Proteomic research of proteins involved in pain expression in an animal model of chronic pain
por: Bellei, Elisa, et al.
Publicado: (2015)

Thalassemias: can we reduce the national burden?
por: Colah, Roshan
Publicado: (2014)

I-2 Can we bypass a muscle metabolic defect?
por: Argov, Z.
Publicado: (2011)

In search of epi-driver genes in head and neck cancer
por: Bhattacharjya, Sumana, et al.
Publicado: (2014)

INSP-09. Using genetically engineered mouse models and patient-derived orthotopic xenografts to develop new therapies for pediatric brain tumors.
por: Jonchere, Barbara, et al.
Publicado: (2022)

INSP-04. Confirmatory adaptive designs for survival trials with several time-to-event endpoints
por: Schmidt, Rene
Publicado: (2022)

INSP-08. Cerebellar mutism syndrome: incidence, symptoms, risk factors, prognosis. Results and future perspectives from the Nordic-European study of the cerebellar mutism syndrome
por: Sehested, Astrid, et al.
Publicado: (2022)

INSP-03. Neuronal regulation of glioma progression
por: Monje, Michelle
Publicado: (2022)

INSP-17. Augmented Drug Delivery for Pediatric Diffuse Midline Glioma using Convection Enhanced Delivery
por: Souweidane, Mark M
Publicado: (2022)

INSP-14. Novel approaches to molecular diagnostics
por: Sahm, Felix
Publicado: (2022)

INSP-07. Improving cognitive outcomes for children treated for cancer: moving beyond the cure
por: Conklin, Heather
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ul6956pks1f0i061if8jbucu3i